Saturday, October 19, 2019 2:10:13 PM
$BNGO $BNGOW
Bionano estimated that the discovery research and cytogenetics markets offer it the opportunity to sell up to approximately 8,500 Saphyr systems for a total of $2.1 billion. In addition, each Saphyr system has the potential to create recurring revenues ranging from about $75,000 to $150,000 per year, for a total of $0.6 billion to $1.3 billion per year. Thus, the firm estimates the size of its total currently addressable genome analysis market to be between $2.7 billion and $3.4 billion.
Bionano estimated that the discovery research and cytogenetics markets offer it the opportunity to sell up to approximately 8,500 Saphyr systems for a total of $2.1 billion. In addition, each Saphyr system has the potential to create recurring revenues ranging from about $75,000 to $150,000 per year, for a total of $0.6 billion to $1.3 billion per year. Thus, the firm estimates the size of its total currently addressable genome analysis market to be between $2.7 billion and $3.4 billion.
Recent BNGO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 08:06:01 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 08:04:43 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 08:02:51 PM
- Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma • GlobeNewswire Inc. • 04/02/2026 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/25/2026 08:28:43 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/23/2026 08:08:58 PM
- Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 • GlobeNewswire Inc. • 03/23/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 08:04:52 PM
- Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 • GlobeNewswire Inc. • 03/09/2026 08:05:00 PM
- Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale • GlobeNewswire Inc. • 02/27/2026 01:00:00 PM
- 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- 11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy • GlobeNewswire Inc. • 02/25/2026 01:00:00 PM
- 9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:31:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:29:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:28:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:26:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:25:37 PM
- Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping • GlobeNewswire Inc. • 02/09/2026 02:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:19:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:18:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:17:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:16:00 PM
